{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:18:23Z","timestamp":1761844703799},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alagille syndrome (AGS) is often associated with symptoms of maldigestion, such as steatorrhea, hypotrophy and growth retardation. Exocrine pancreatic insufficiency was proposed as the underlying cause. We aimed to assess the exocrine pancreatic function with the use of different methods in AGS patients. Concentrations of fecal elastase-1 (FE1) and fecal lipase (FL) activities were measured in 33 children with AGS. The C-mixed triglyceride breath test (MTBT) in a subgroup comprising 15 patients. In all patients studied, FE1 concentrations and FL activities were normal. Abnormal MTBT results were documented in 4 (26.7%) patients. The FE1 and FL levels in MTBT-positive and MTBT-negative children did not differ. The results of this research do not confirm the presence of exocrine pancreatic dysfunction in AGS patients. Routine screening for exocrine pancreatic insufficiency of this group of patients is not necessary.<\/jats:p>","DOI":"10.1038\/srep35229","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T11:04:49Z","timestamp":1476702289000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exocrine pancreatic function in children with Alagille syndrome"],"prefix":"10.1038","volume":"6","author":[{"given":"Dorota","family":"Gliwicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldona","family":"Wierzbicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mi\u015bkiewicz-Chotnicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Lisowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Walkowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"BFsrep35229_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ejhg.2011.181","volume":"20","author":"PD Turnpenny","year":"2012","unstructured":"Turnpenny, P. D. & Ellard, S. Alagille syndrome: pathogenesis, diagnosis and management. Eur. J. Hum. Genet. EJHG 20, 251\u2013257 (2012).","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"BFsrep35229_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00005176-198911000-00009","volume":"9","author":"SK Chong","year":"1989","unstructured":"Chong, S. K., Lindridge, J., Moniz, C. & Mowat, A. P. Exocrine pancreatic insufficiency in syndromic paucity of interlobular bile ducts. J. Pediatr. Gastroenterol. Nutr. 9, 445\u2013449 (1989).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFsrep35229_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/hep.510290331","volume":"29","author":"KM Emerick","year":"1999","unstructured":"Emerick, K. M. et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatol. Baltim. Md 29, 822\u2013829 (1999).","journal-title":"Hepatol. Baltim. Md"},{"key":"BFsrep35229_CR4","doi-asserted-by":"crossref","unstructured":"Golson, M. L., Loomes, K. M., Oakey, R. & Kaestner, K. H. Ductal malformation and pancreatitis in mice caused by conditional Jag1 deletion. Gastroenterology 136, 1761\u20131771.e1 (2009).","DOI":"10.1053\/j.gastro.2009.01.040"},{"key":"BFsrep35229_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/jhep.2000.16600","volume":"32","author":"C Crosnier","year":"2000","unstructured":"Crosnier, C. et al. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatol. Baltim. Md 32, 574\u2013581 (2000).","journal-title":"Hepatol. Baltim. Md"},{"key":"BFsrep35229_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/MPG.0b013e31825eff61","volume":"55","author":"BM Kamath","year":"2012","unstructured":"Kamath, B. M., Piccoli, D. A., Magee, J. C. & Sokol, R. J. Pancreatic insufficiency is not a prevalent problem in Alagille syndrome. J. Pediatr. Gastroenterol. Nutr. 55, 612\u2013614 (2012).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFsrep35229_CR7","first-page":"1042","volume":"93","author":"J Walkowiak","year":"2004","unstructured":"Walkowiak, J. et al. Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis. Acta Paediatr. Oslo Nor.1992 93, 1042\u20131045 (2004).","journal-title":"Acta Paediatr. Oslo Nor.1992"},{"key":"BFsrep35229_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00005176-200210000-00007","volume":"35","author":"AJ Rovner","year":"2002","unstructured":"Rovner, A. J. et al. Rethinking growth failure in Alagille syndrome: the role of dietary intake and steatorrhea. J. Pediatr. Gastroenterol. Nutr. 35, 495\u2013502 (2002).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFsrep35229_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000086545","volume":"5","author":"W-H Wen","year":"2005","unstructured":"Wen, W.-H. et al. Fecal elastase 1, serum amylase and lipase levels in children with cholestasis. Pancreatol. Off. J. Int. Assoc. Pancreatol. IAP Al 5, 432\u2013437 (2005).","journal-title":"Pancreatol. Off. J. Int. Assoc. Pancreatol. IAP Al"},{"key":"BFsrep35229_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00005176-200502000-00001","volume":"40","author":"J Walkowiak","year":"2005","unstructured":"Walkowiak, J. et al. Indirect pancreatic function tests in children. J. Pediatr. Gastroenterol. Nutr. 40, 107\u2013114 (2005).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFsrep35229_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/01.mpg.0000218154.26792.6a","volume":"42","author":"J Walkowiak","year":"2006","unstructured":"Walkowiak, J. et al. Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2. J. Pediatr. Gastroenterol. Nutr. 42, 416\u2013418 (2006).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFsrep35229_CR12","first-page":"573","volume":"57","author":"J Walkowiak","year":"2010","unstructured":"Walkowiak, J. et al. Normal levels of serum pancreatic enzymes in patients with progressive familial intrahepatic cholestasis type 2. Acta Biochim. Pol. 57, 573\u2013575 (2010).","journal-title":"Acta Biochim. Pol."},{"key":"BFsrep35229_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/00005176-199910000-00011","volume":"29","author":"RE Quiros-Tejeira","year":"1999","unstructured":"Quiros-Tejeira, R. E. et al. Variable morbidity in alagille syndrome: a review of 43 cases. J. Pediatr. Gastroenterol. Nutr. 29, 431\u2013437 (1999).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFsrep35229_CR14","first-page":"18","volume":"5","author":"I Palczewska","year":"2001","unstructured":"Palczewska, I. & Nied\u017awiecka, Z. [Somatic development indices in children and youth of Warsaw]. In Polish. Med. Wieku Rozwoj. 5, 18\u2013118 (2001).","journal-title":"Med. Wieku Rozwoj"},{"key":"BFsrep35229_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s004310000536","volume":"159","author":"J Walkowiak","year":"2000","unstructured":"Walkowiak, J. Faecal elastase-1: clinical value in the assessment of exocrine pancreatic function in children. Eur. J. Pediatr. 159, 869\u2013870 (2000).","journal-title":"Eur. J. Pediatr."},{"key":"BFsrep35229_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1569-1993(02)00096-6","volume":"1","author":"J Walkowiak","year":"2002","unstructured":"Walkowiak, J. et al. Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis. J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc. 1, 260\u2013264 (2002).","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc"},{"key":"BFsrep35229_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3109\/00365513.2010.486869","volume":"70","author":"A Lisowska","year":"2010","unstructured":"Lisowska, A. et al. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Scand. J. Clin. Lab. Invest. 70, 322\u2013326 (2010).","journal-title":"Scand. J. Clin. Lab. Invest."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep35229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35229","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:42:05Z","timestamp":1672886525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep35229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep35229"],"URL":"https:\/\/doi.org\/10.1038\/srep35229","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,17]]},"assertion":[{"value":"4 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35229"}}